KIDNEY JACKET
DEAD

Serial Number

79375221

Owner

IISHIELD PTY LTD

Attorney

Jennifer A. Visintine

Filing Date

Mar 30, 2023

Add to watchlist:

No watchlists yet
View on USPTO

KIDNEY JACKET Trademark

Serial Number: 79375221

KIDNEY JACKET is a trademark filed by IISHIELD PTY LTD on March 30, 2023. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

IISHIELD PTY LTD (3 trademarks)

2-4 Cornwallis St

Entity Type: 99

Trademark Details

Filing Date

March 30, 2023

Registration Date

Not Registered

Goods & Services

Renal scanning agents for medical use being pharmaceutical preparations for use in ex-vivo and in-vivo diagnosis of kidney disorders; renal scanning agents for medical use being pharmaceutical preparations for use in in-vivo diagnosis of kidney disorders; in-vivo and ex-vivo diagnostic materials for medical use being pharmaceutical preparations for the diagnosis of kidney disorders; diagnostic testing materials for medical use being pharmaceutical preparations for use in the diagnosis of kidney disorders; in-vivo diagnostic materials for medical use being pharmaceutical preparations for use in the diagnosis of kidney disorders; in-vivo and ex-vivo diagnostic preparations for medical use being pharmaceutical preparations for use in the diagnosis of kidney disorders; diagnostic preparations for medical use in-vivo diagnosis being pharmaceutical preparations for use in the diagnosis of kidney disorders; in-vivo and ex-vivo radiodiagnostic agents for medical use being pharmaceutical preparations for use in the radiodiagnosis of kidney disorders; diagnostic scanning agents for in-vivo use being pharmaceutical preparations for use in the diagnosis of kidney disorders; in vivo medical diagnostic scanning agents for medical use being pharmaceutical preparations for use in the diagnosis of kidney disorders; pharmaceutical preparations for the preservation and storage of human organs between transplant surgeries; pharmaceutical preparations for the preservation and storage of human organs; solutions for medical use being pharmaceutical preparations for use in the preservation of organs between transplant surgeries; solutions for medical use being pharmaceutical preparations for use in the storage of organs between transplant surgeries

medical supports for the body, namely, a medical sheath for the encasement of donor transplant organs during storage and transportation; medical supports for the body, namely, a medical sheath for the encasement of donor transplant organs during transplantation surgery; surgical apparatus for use in transplant surgery, namely, a medical sheath for the encasement of donor transplant organs during storage and transportation; surgical implants comprised of artificial materials; medical apparatus and instruments for the purposes of long-term graft survival during organ transplant surgery; medical apparatus and instruments for the purposes of short-term graft preservation during organ transplant surgery

Research and development of technology in the field of maintenance, preservation, transportation and storage of organs in-vivo and ex-vivo; research and development of new products for others; scientific research to develop new products; scientific research into the development of new products; technical research into the development of new products; medical research services in relation to maintaining and improving the quality of organs in-vivo and ex-vivo; medical and pharmacological research services; medical research, namely, analysis of tissues for medical research; medical and scientific research, namely, conducting clinical trials for others; medical research; scientific research for medical purposes; pharmacological research not for medical purposes, namely, conducting pharmacological testing on organs and body parts in-vivo and ex-vivo; advisory services relating to pharmacology; consultancy pertaining to pharmacology; medical and scientific research, namely, conducting clinical trials for others; providing information about medical and scientific research in the field of pharmaceuticals, clinical trials and organ transplant surgeries; providing scientific research information and information about new product design, including online; scientific research consultancy in the field of pharmaceuticals, clinical trials and organ transplant surgeries; scientific research

Filing History

NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
May 28, 2026 DENC
DEATH OF INTERNATIONAL REGISTRATION
May 28, 2026 DETH
FINAL DECISION TRANSACTION PROCESSED BY IB
Mar 19, 2026 FINT
FINAL DISPOSITION NOTICE SENT TO IB
Mar 5, 2026 FICS
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Mar 5, 2026 FICR
ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Mar 5, 2025 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Mar 5, 2025 ABN2
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Jan 10, 2025 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Dec 25, 2024 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Dec 25, 2024 OPNR
REFUSAL PROCESSED BY IB
Sep 21, 2024 RFNT
NON-FINAL ACTION WRITTEN
Aug 19, 2024 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 17, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 17, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 17, 2024 TROA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 15, 2024 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Jul 15, 2024 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jul 15, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jul 15, 2024 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jul 15, 2024 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jul 15, 2024 COAR
REFUSAL PROCESSED BY IB
Feb 6, 2024 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jan 18, 2024 RFCS
REFUSAL PROCESSED BY MPU
Jan 18, 2024 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Dec 30, 2023 RFCR
NON-FINAL ACTION WRITTEN
Dec 29, 2023 CNRT
ASSIGNED TO EXAMINER
Dec 26, 2023 DOCK
APPLICATION FILING RECEIPT MAILED
Aug 15, 2023 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 10, 2023 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Aug 8, 2023 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jul 27, 2023 REPR